Still in breast cancer, the interaction between the nuclear protein nucleolin and COUP-TFII led to the expression of RARβ2, and the nucleolin over-expression led to the expression of RARβ2, normally reduced in breast cancer [180]. This evidence concerns the gene NUCLEOLIN and breast carcinoma.